Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 5/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.49 |
| ▸ | ESR1 | P03372 | 1/20 | 0.49 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.49 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.49 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | GGT1 | P19440 | 1/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.49 |
| ▸ | BACE1 | P56817 | 3/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3728321 | 0.87 | KDM4E (0.58) | LMNATDP1MAPK1L3MBTL1TSHR | |
| SCHEMBL27849556 | 0.87 | ADORA3 (0.55) | MAOBLMNATDP1MAPK1L3MBTL1 | |
| SCHEMBL6447567 | 0.86 | LMNA (0.55) | LMNATDP1MAPK1L3MBTL1KDM4E | |
| SCHEMBL709954 | 0.86 | LMNA (0.51) | MAOBLMNATDP1MAPK1L3MBTL1 | |
| SCHEMBL9788610 | 0.86 | BACE1 (0.56) | LMNATDP1MAPK1TSHRKDM4E | |
| SCHEMBL10448930 | 0.86 | PREP (0.53) | LMNATDP1MAPK1TSHRKDM4E | |
| SCHEMBL27559161 | 0.85 | BACE1 (0.58) | MAOBLMNATDP1MAPK1L3MBTL1 | |
| Bicarbonate SCHEMBL9330276 | 0.85 | KDM4E (0.56) | LMNATDP1MAPK1L3MBTL1TSHR | |
| SCHEMBL16192590 | 0.85 | LMNA (0.48) | MAOBLMNATDP1MAPK1L3MBTL1 | |
| SCHEMBL10783055 | 0.84 | SMN1; SMN2 (0.53) | MAOBLMNATDP1MAPK1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108601958-B | Pro-fragrance compositions | 爱客多有限公司 | 2022-06-17 | — | — | CN | claimed |
| EP-2211829-B1 | IMPROVEMENT OF THE FRAGRANCE EFFECT OF PERFUME ESTERS | HENKEL AG & CO KGAA (DE) | 2011-04-27 | — | — | EP | claimed |
| US-20100210496-A1 | Fragrance Effect of Perfume Esters | BESSLER CORNELIUS | 2010-08-19 | — | — | US | claimed |
| EP-4192614-B1 | PROCESS FOR THE PREPARATION OF MICROCAPSULES | SYMRISE AG (DE) | 2026-05-06 | — | — | EP | disclosed |
| US-12583833-B2 | Enrichment of a diastereomer in Magnolan | SYMRISE AG (DE) | 2026-03-24 | — | — | US | disclosed |
| EP-4687810-A1 | PREPARATIONS COMPRISING HYDROXY PINACOLONE RETINOATE | Symrise AG (DE) | 2026-02-11 | — | — | EP | disclosed |
| EP-4692252-A1 | FUNCTIONAL PARTICLE DISPERSION | MITSUBISHI PENCIL COMPANY, LIMITED (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-12545851-B2 | Fragrances with note of lily of the valley | SYMRISE AG (DE) | 2026-02-10 | — | — | US | disclosed |
| US-12453693-B2 | Encapsulated fragrance compounds based on natural amino acids | SYMRISE AG (DE) | 2025-10-28 | — | — | US | disclosed |
| US-12409433-B2 | Microcapsules | SYMRISE AG (DE) | 2025-09-09 | — | — | US | disclosed |
| US-20250144589-A1 | Method for Producing Microcapsules | SYMRISE AG (DE) | 2025-05-08 | — | — | US | disclosed |
| EP-0659179-A1 | BENZO-FUSED LACTAMS PROMOTE RELEASE OF GROWTH HORMONE | MERCK & CO. INC. (US) | 1995-06-28 | — | — | EP | disclosed |
| US-5310737-A | Benzo-fused lactams that promote the release of growth hormone | MERCK & CO., INC. (US) | 1994-05-10 | — | — | US | disclosed |
| WO-1994005634-A1 | BENZO-FUSED LACTAMS PROMOTE RELEASE OF GROWTH HORMONE | MERCK & CO., INC. (US) | 1994-03-17 | — | — | WO | disclosed |
| US-5283241-A | Animal growth regulators | MERCK & CO., INC. (US) | 1994-02-01 | — | — | US | disclosed |
| US-5206235-A | Animal growth regulators; stimulants | MERCK & CO., INC. (US) | 1993-04-27 | — | — | US | disclosed |
| EP-0513974-A1 | Novel benzo-fused lactams that promote the release of growth hormone | MERCK & CO. INC. (US) | 1992-11-19 | — | — | EP | disclosed |
| WO-1992016524-A1 | BENZO-FUSED LACTAMS PROMOTE RELEASE OF GROWTH HORMONE | MERCK & CO., INC. (US) | 1992-10-01 | — | — | WO | disclosed |
| US-4524017-A | Derivatives of norbornanes having hydrocarbon side chains and perfume compositions containing the same | NIPPON PETROCHEMICALS CO., LTD. (JP) | 1985-06-18 | — | — | US | disclosed |
| US-4033993-A | Cycloalkyl carbonates | HENKEL & CIE G.M.B.H. (DT) | 1977-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12583833-B2 | Enrichment of a diastereomer in Magnolan | TRPA1, ENO1, ADH1A | MAOB 1014/4885LMNA 1005/4885TDP1 3089/4885 |
| US-12453693-B2 | Encapsulated fragrance compounds based on natural amino acids | SMS, CUTA, SRM | MAOB 947/4885LMNA 4455/4885TDP1 4443/4885 |
| US-12545851-B2 | Fragrances with note of lily of the valley | TRPA1, CDY1; CDY1B, TMEM109 | MAOB 230/4885LMNA 2825/4885TDP1 3981/4885 |
| US-12409433-B2 | Microcapsules | TERT, TTPA, TERB1 | MAOB 2112/4885LMNA 2360/4885TDP1 1150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.